PANASONIC
26.5.2020 12:50:05 CEST | Business Wire | Press release
Panasonic Center Tokyo (3-5-1 Ariake, Koto-ku, Tokyo, Japan. Referred to as "PC Tokyo"), the corporate global communications hub for Panasonic, has been conducting various communication activities as a corporate pavilion through exhibitions and offline events.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005385/en/
Due to the unprecedented circumstances around the world today, people's daily lives and values have been significantly impacted. We, at Panasonic, believe a new approach blending online and offline communication activities will be an essential element for corporate pavilions now more than ever.
Based on this perspective, we have decided to host an online event called "The power to create the future", on Sunday, May 31, 2020. An event dedicated to children, who we believe have the ability to become "change makers" and bring a positive impact to society, to create a better world.
The theme of the event is "STEAM education*", a very important element required for future education as the world is rapidly changing. During the event, STEAM professionals will conduct a workshop which will give the participants an opportunity to think and understand more about STEAM in their daily lives. Olympian Katie Ledecky will also join the event to introduce the Dive Into STEM Education, Powered by Panasonic program.
Katie Ledecky's Dive Into STEM Education Powered by Panasonic is an interactive educational program created to inspire students to pursue careers in science, technology, engineering and mathematics.
The students participating in the event will be divided into different groups where they will conduct a series of interviews with our guests to learn more about STEAM, and then will make a presentation about what they have learned. At the end of the event, participants will hear from Katie, who is actively working on educational support activities for younger generations.
PC Tokyo aims to proactively support the education program of younger generations by providing fresh contents such as videos of online events available on the pavilion's website.
Message from Katie Ledecky towards the event
"I am thrilled to join Panasonic Center Tokyo to promote STEM education to a group of Japanese students on May 31st.
All are welcome to join our training workshop. Hope to see you soon."
Video: “Katie Ledecky's Dive Into STEM Education Powered by Panasonic”
https://youtu.be/31DmQXq0sTw
*STEAM education is an educational method which was proposed by adding Art to "STEM education"; a method to learn about Science, Technology, Engineering, and Mathematics comprehensively.
STEAM education was introduced in the United States to contribute to the development of younger generations to inspire them to pursue diverse career fields. This method is also attracting a lot of attention in Japan in recent years.
"The power to create the future" Event outline
Date
Saturday, May 30, 2020 at 6:00pm-7:40pm PDT / 9:00pm-10:40pm EDT
Sunday, May 31, 2020 at 10:00am-11:40am JST
Place
Live stream of the online event: https://youtu.be/aiLyPX7SmTM
Details: https://www.panasonic.com/global/corporate/center-tokyo/en.html#steam_0531
*The live stream is recorded and can be viewed afterwards.
Target
Junior and senior high school students, educators, and those who have interest in STEAM education
Cooperation
Kyodo News (junior press), EverFi (contents for the event)
*The event will be conducted in English. Admission free.
About Panasonic
Panasonic Corporation is a global leader developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, and B2B sectors. The company, which celebrated its 100th anniversary in 2018, operates 528 subsidiaries and 72 associated companies worldwide and reported consolidated net sales of 7.49 trillion yen for the year ended March 31, 2020. Committed to pursuing new value through collaborative innovation, the company uses its technologies to create a better life and a better world for customers. Learn more about Panasonic: https://www.panasonic.com/global .
Source: https://news.panasonic.com/global/topics/2020/78373.html
Related Links
Panasonic Center Tokyo official website
https://panasonic.com/global/center-tokyo/en/
Event Reports - Panasonic Center TOKYO
https://www.panasonic.com/global/corporate/center-tokyo/en/event_report.html#StayHome_contents
Video: Panasonic Partners With The Michael Phelps Foundation #whatmovesus
https://channel.panasonic.com/contents/28784/
Video: Team Panasonic is forward moving #whatmovesus
https://channel.panasonic.com/contents/28785/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005385/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom